SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

ANG Lifesciences India informs about trading window closure

25 Sep 2024 Evaluate
ANG Lifesciences India has informed that the trading window for dealing in the securities of the Company shall remain closed from 01st October, 2024 for the insider, designated persons of the company and their immediate relatives, till the end of 48 hours after declaration of the Unaudited Standalone and Consolidated Financial Results of the Company for the half year and quarter ended on 30th September, 2024. The date of Board Meeting for consideration of Unaudited Standalone and Consolidated Financial Results for the half year and quarter ended 30th September, 2024 shall be intimated separately.

The above information is a part of company’s filings submitted to BSE.

ANG Lifesciences Share Price

26.84 0.28 (1.05%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×